AMPK activation: a therapeutic target for type 2 diabetes?

AMPK activation: a therapeutic target for type 2 diabetes?

Kimberly A Coughlan, Rudy J Valentine, Neil B Ruderman, Asish K Saha Endocrinology and Diabetes, Department of Medicine, Boston University Medical Center, Boston, MA, USA Abstract: Type 2 diabetes (T2D) is a metabolic disease characterized by insulin resistance, β-cell dysfunction, and el...

Full description

Bibliographic Details
Main Authors:	Coughlan KA, Valentine RJ, Ruderman NB, Saha AK
Format:	Article
Language:	English
Published:	Dove Medical Press 2014-06-01
Series:	Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Online Access:	http://www.dovepress.com/ampk-activation-a-therapeutic-target-for-type-2-diabetes-a17323

Similar Items

AMP-activated protein kinase (AMPK) as therapeutic target
by: Elżbieta Sarnowska, et al.
Published: (2013-08-01)

An AMPK activator as a therapeutic option for congenital nephrogenic diabetes insipidus
by: Janet D. Klein, et al.
Published: (2021-04-01)

AMPK: Potential Therapeutic Target for Vascular Calcification
by: Yi Lu, et al.
Published: (2021-05-01)

Development of therapeutic agents for type II DM by using AMPK as molecular target
by: Wei-Lu Chen, et al.
Published: (2007)

Nutrient Excess and AMPK Downregulation in Incubated Skeletal Muscle and Muscle of Glucose Infused Rats.
by: Kimberly A Coughlan, et al.
Published: (2015-01-01)

Antidiabetic activity of Callicarpa nudiflora extract in type 2 diabetic rats via activation of the AMPK-ACC pathway
by: Wen-Yu Ma, et al.
Published: (2019-01-01)

High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
by: Philip J. Barter
Published: (2013-09-01)

Yoga as a therapeutic intervention for the management of type 2 diabetes mellitus
by: Santwana Mondal, et al.
Published: (2018-01-01)

The Mechanism of a Novel AMPK Activator in Diabetic Wound Healing
by: Chiang Min-Hsien, et al.
Published: (2014)

Oleuropein alleviates gestational diabetes mellitus by activating AMPK signaling
by: Zhiwei Zhang, et al.
Published: (2021-02-01)

5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications
by: Fan Yao, et al.
Published: (2016-01-01)

The effect of crocin supplementation on glycemic control, insulin resistance and active AMPK levels in patients with type 2 diabetes: a pilot study
by: Vahideh Behrouz, et al.
Published: (2020-07-01)

Long Noncoding RNAs as Diagnostic and Therapeutic Targets in Type 2 Diabetes and Related Complications
by: Fatjon Leti, et al.
Published: (2017-08-01)

Challenges to hemoglobin A1c as a therapeutic target for type 2 diabetes mellitus
by: Masayuki Ikeda, et al.
Published: (2019-07-01)

Inhibition of AMPK via phosphorylation at Ser485/491: multiple mechanisms of regulation
by: Coughlan, Kimberly A.
Published: (2016)

Myeloid AMPK in Atherosclerosis: Therapeutic Potential and Associated Mechanisms
by: LeBlond, Nicholas
Published: (2020)

Therapeutic Targeting of the IGF Axis
by: Eliot Osher, et al.
Published: (2019-08-01)

Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue
by: X. Julia Xu, et al.
Published: (2012-04-01)

Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes.
by: Shicheng Cao, et al.
Published: (2012-01-01)

FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway
by: Hong Wang, et al.
Published: (2021-06-01)

Epe1 contributes to activation of AMPK by promoting phosphorylation of AMPK alpha subunit, Ssp2
by: Yongyi Chen, et al.
Published: (2017-06-01)

Myeloid deletion and therapeutic activation of AMPK do not alter atherosclerosis in male or female mice
by: Nicholas D. LeBlond, et al.
Published: (2020-12-01)

Curcumin ameliorates gestational diabetes in mice partly through activating AMPK
by: Xuehong Lu, et al.
Published: (2019-01-01)

Berberine improves kidney function in diabetic mice via AMPK activation.
by: Long Zhao, et al.
Published: (2014-01-01)

AMPK as Target for Intervention in Childhood and Adolescent Obesity
by: Joselyn Rojas, et al.
Published: (2011-01-01)

AMPK-Targeted Effector Networks in Mycobacterial Infection
by: Eun-Kyeong Jo, et al.
Published: (2019-03-01)

Therapeutic Target Achievement in Type 2 Diabetic Patients after Hyperglycemia, Hypertension, Dyslipidemia Management
by: Ah Young Kang, et al.
Published: (2011-06-01)

Dicarbonyl Protein Adduction: Plasminogen as a Target and Metformin as a Scavenging Therapeutic in Type 2 Diabetes
by: Kinsky, Owen Robert
Published: (2014)

Past and current perspective on new therapeutic targets for Type-II diabetes
by: Patil PD, et al.
Published: (2017-05-01)

Neoepitopes in Type 1 Diabetes: Etiological Insights, Biomarkers and Therapeutic Targets
by: Teresa Rodriguez-Calvo, et al.
Published: (2021-04-01)

Targeted inactivation of GPR26 leads to hyperphagia and adiposity by activating AMPK in the hypothalamus.
by: Daohong Chen, et al.
Published: (2012-01-01)

Therapeutic Role of Yoga in Type 2 Diabetes
by: Arkiath Veettil Raveendran, et al.
Published: (2018-08-01)

THERAPEUTIC EFFICACY OF COMBINATION OF MTOR INHIBITORS AND AMPK ACTIVATORS IN NON-SMALL CELL LUNG CANCER.
by: Corriea, Grinal
Published: (2014)

Discovery and translation of a target engagement marker for AMP-activated protein kinase (AMPK).
by: Rolf Grempler, et al.
Published: (2018-01-01)

Retraction: Berberine Improves Kidney Function in Diabetic Mice via AMPK Activation.
by: PLOS ONE Editors
Published: (2017-01-01)

PYY, a Therapeutic Option for Type 2 Diabetes?
by: Claudia Guida, et al.
Published: (2020-01-01)

Implications of publicly available genomic data resources in searching for therapeutic targets of obesity and type 2 diabetes
by: Sungwon Jung
Published: (2018-04-01)

Diet quality and therapeutic targets in patients with type 2 diabetes: evaluation of concordance between dietary indexes
by: Juliana Peçanha Antonio, et al.
Published: (2017-11-01)

Analysis of Communal Molecular Mechanism and Potential Therapeutic Targets in Heart Failure and Type 2 Diabetes Mellitus
by: Wang Z, et al.
Published: (2021-10-01)

Revascularisation of type 2 diabetics with coronary artery disease: Insights and therapeutic targeting of O-GlcNAcylation
by: Bolanle, I.O., et al.
Published: (2021)